GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock

NCT01315496 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Sepsis
Septic Shock

Interventions

DRUG: Immunoglobulin G

Sponsor

Green Cross Corporation

Collaborators

[object Object]